Literature DB >> 12546515

Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer.

M Bortolami1, C Venturi, L Giacomelli, R Scalerta, S Bacchetti, F Marino, A Floreani, M Lise, R Naccarato, F Farinati.   

Abstract

BACKGROUND: Kupffer cells, monocytes and infiltrating T cells have been considered the major source of interleukin-1beta and tumour necrosis factor-alpha in the liver. AIMS; To explore the expression of interleukin-1beta and tumour necrosis factor-alpha and to evaluate the density and the distribution of T lymphocytes and monocytes/macrophages in the liver of patients with primary and secondary tumours.
METHODS: Tumoural and peritumoural liver samples were examined from 21 patients with hepatocellular carcinoma, 10 with hepatic metastases, 5 with benign focal liver lesions and 4 healthy adult livers. Interleukin-1beta and tumour necrosis factor-alpha mRNAs were detected by a semiquantitative comparative reverse transcriptase polymerase chain reaction. T lymphocytes and monocytes/macrophages were detected by immunohistochemistry.
RESULTS: Higher levels of interleukin-1beta, tumour necrosis factor-alpha, CD3+ and CD68+ cells were found in the tissue surrounding hepatocellular carcinoma and metastases than in the tumour itself. A strong expression of CD68+ and CD3+ cells was found mainly along the tumour-host interface but the highest expression of CD3+ cells was found at the metastasis interfaces. Interleukin-1beta expression, CD3+ and CD68+ cell densities were higher in peritumoural samples than in so-called "normal" liver tissue.
CONCLUSIONS: An increased production of interleukin-1beta and, to a lesser extent, of tumour necrosis factor-alpha mRNA coincides with the presence of cancer be it primary or secondary, both in healthy and cirrhotic livers. The presence of cancer, irrespective of the presence of underlying liver damage, appears to play the most important role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12546515     DOI: 10.1016/s1590-8658(02)80073-1

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  13 in total

1.  Role of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinoma.

Authors:  Moana Gelu-Simeon; Didier Samuel
Journal:  Hepatol Int       Date:  2013-09-10       Impact factor: 6.047

2.  Association of Interleukin-1β and Gene Polymorphisms with Liver Pathogenesis in Hepatitis B Virus Infection among Eastern Indian Population.

Authors:  Avik Biswas; Rajesh Panigrahi; Manisha Pal; Binay K De; Sekhar Chakrabarti; Mrinmoy K Ghosh; Bikash C Chandra Seth; Susanta Roychowdhury; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2013-12-04

3.  Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis.

Authors:  Melchiorre Cervello; Daniela Foderàa; Ada Maria Florena; Maurizio Soresi; Claudio Tripodo; Natale D'Alessandro; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

4.  Bax inhibitor-1 down-regulation in the progression of chronic liver diseases.

Authors:  Andromachi Kotsafti; Fabio Farinati; Romilda Cardin; Patrizia Burra; Marina Bortolami
Journal:  BMC Gastroenterol       Date:  2010-04-01       Impact factor: 3.067

5.  Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection.

Authors:  Yi-Wei Li; Shuang-Jian Qiu; Jia Fan; Qiang Gao; Jian Zhou; Yong-Sheng Xiao; Yang Xu; Xiao-Ying Wang; Jian Sun; Xiao-Wu Huang
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-10       Impact factor: 4.553

Review 6.  Immunology of hepatocellular carcinoma.

Authors:  Meenakshi Sachdeva; Yogesh K Chawla; Sunil K Arora
Journal:  World J Hepatol       Date:  2015-08-18

7.  A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.

Authors:  Olfat Hammam; Ola Mahmoud; Manal Zahran; Azza Sayed; Rabab Salama; Karim Hosny; Ahmed Farghly
Journal:  Gastrointest Cancer Res       Date:  2013-07

8.  Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection.

Authors:  Nattiya Hirankarn; Ingorn Kimkong; Pittaya Kummee; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

Review 9.  Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway.

Authors:  Romilda Cardin; Marika Piciocchi; Marina Bortolami; Andromachi Kotsafti; Luisa Barzon; Enrico Lavezzo; Alessandro Sinigaglia; Kryssia Isabel Rodriguez-Castro; Massimo Rugge; Fabio Farinati
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

10.  Hepatocellular carcinoma in patients with autoimmune hepatitis.

Authors:  Andreas Teufel; Arndt Weinmann; Catherine Centner; Anja Piendl; Ansgar W Lohse; Peter R Galle; Stephan Kanzler
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.